Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
about
High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives.PSA Doubling Time Predicts for the Development of Distant Metastases for Patients Who Fail 3DCRT Or IMRT Using the Phoenix Definition.Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trialSimultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study.Monte Carlo simulation of a compact microbeam radiotherapy system based on carbon nanotube field emission technology.Robust plan optimization using edge-enhanced intensity for intrafraction organ deformation in prostate intensity-modulated radiation therapyMR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer.Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinomaPlanning and delivery of intensity-modulated radiation therapy.Comparison of daily couch shifts using MVCT (TomoTherapy) and B-mode ultrasound (BAT System) during prostate radiotherapy.Incorporation of gantry angle correction for 3D dose prediction in intensity-modulated radiation therapy.A validation of carbon fiber imaging couch top modeling in two radiation therapy treatment planning systems: Philips Pinnacle3 and BrainLAB iPlan RT Dose.Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon.Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?Dose-volume factors to select patient-specific image-guidance action thresholds in prostate cancer.Determination of the photon beam attenuation by the BrainLAB imaging couch: angular and field size dependence.Three-dimensional dose prediction based on two-dimensional verification measurements for IMRT.Treatments of exceptionally large prostate cancer patients with low-energy intensity-modulated photons.Dosimetric Studies of Mixed Energy Intensity Modulated Radiation Therapy for Prostate Cancer Treatments
P2860
Q34024161-7C0B92D2-B950-4AE5-9748-5B3DFC14B6E9Q35400436-4876144F-841F-45C3-96CE-8E33E68F8795Q35844052-519578EE-8F11-412C-B69C-089CEF959A13Q36138138-EF7599A8-A825-45C5-95E1-F996128B31D4Q36139213-683F2850-E9A5-45E6-9B07-B34210D612EFQ36304319-D29DAA9C-E5F3-43E5-ADD9-529D9785378BQ36321659-2F43682B-76F5-4232-B219-656D759C50AAQ36325030-5C61142B-5919-4865-9F1A-F667E6E3969CQ36866123-D314807F-2A13-4A20-A19F-450598E66BF3Q36921562-469C1210-FD75-4EA1-B9F9-A236CB93520BQ37379087-0A6CB61B-2874-488A-9C43-282037F29A1BQ40039383-67A39567-1982-44C7-B0DA-0D0752FE8B09Q40521147-FC888D2D-21F1-4F59-9F35-870303B7DA6CQ42038486-4FFDB425-9EFD-46B3-BFFC-D97973DCB81AQ42941156-0FA626A2-C2AC-4149-BDE3-63533960F1A8Q42981640-7FF01A9D-2ED8-4EF2-8FE0-DAB21466AA36Q50682681-4ABF98B6-03C9-4D19-A59B-6BA7823C2493Q54942599-8AECEB22-C0EE-4E6A-9ED9-75E9DD536FCFQ55100486-C65F1665-E330-4695-AC33-B532E6EE63F6Q55511975-66A7930E-F491-44EE-8CD2-E5DA3B5E1B87Q59051507-DC7AD42D-A0FB-46A3-A18A-2C1A34A9043F
P2860
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@ast
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@en
type
label
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@ast
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@en
prefLabel
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@ast
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@en
P2093
P1476
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
@en
P2093
Alan Pollack
Alex Hanlon
Eric M Horwitz
Robert A Price
Robert G Uzzo
Steven Feigenberg
P2888
P304
P356
10.1007/S00345-003-0356-X
P577
2003-09-05T00:00:00Z